Deutsche Bank Aktiengesellschaft »

Avita Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $221k 16k 13.72
2023-09-30 $227k 16k 14.61
2023-06-30 $193k 11k 17.01
2022-03-31 $120k 14k 8.47
2021-12-31 $183k 16k 11.65
2021-09-30 $269k 15k 18.01
2021-06-30 $304k 15k 20.13